OverviewAI-generated
Galápagos NV, also known as Galapagos Genomics, is a company established in 1999. It is located in Mechelen, Belgium, and maintains an active status. The organization operates within the pharmaceutical preparations industry, classified under the Standard Industrial Classification code 2834.
The entity is registered with the Central Index Key 0001421876 and is categorized as an other entity type. Its state of incorporation is listed as C9. Galápagos NV is associated with the ticker symbols LKFT, GLPGF, and GLPG, and trades on the Nasdaq and OTC exchanges. The most recent filing form submitted was a 6-K, dated 2026-05-27.
Synthesized by Vinony from 23 facts across 4 sources: Wikidata, Firecrawl, SEC EDGAR, ROR. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Company
LKFT, GLPGF, GLPG- Industry
- Pharmaceutical Preparations
- Exchange
- Nasdaq, OTC
- State of incorporation
- C9
- Entity type
- other
- Latest filing
- 6-K · 2026-05-27
- Jurisdiction
- BE
- Headquarters
- Mechelen, BE
Research organization · ROR
- Type
- Company
- Founded
- 1999
- Location
- Mechelen, Belgium
- Also known as
- Galapagos Genomics
- Status
- Active
GRID grid.476376.7 · ISNI 0000 0004 0603 3591
Wikidata facts
- Instance of
- public company
- Country
- Belgium
- Headquarters
- Mechelen
- Industry
- pharmaceutical industry
- Stock exchange
- Amsterdam Stock Exchange
- Official website
- www.glpg.com
- Image
- Darwinweg 24 Leiden.jpg
Show 2 more facts
- inception
- 1999-00-00
- Commons category
- Galapagos (company)
Sources (8)
via Wikidata · CC0
~6 min read
Encyclopedic overview
[Skip to content](http://www.glpg.com/#main)
▁ -
Excerpted from Wikipedia’s “Galápagos NV” article, available under the CC BY-SA 4.0 licence.